Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.45 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2473803 | 1.00 | SMPD1 (0.46) | SMPD1FDPSGPR84PPARGPPARD | |
| SCHEMBL2230483 | 0.92 | FDPS (0.42) | SMPD1FDPSGPR84PPARGPPARD | |
| Bicarbonate SCHEMBL9751030 | 0.87 | GPR84 (0.52) | SMPD1FDPSGPR84PPARGPPARD | |
| Bicarbonate SCHEMBL829821 | 0.87 | GPR84 (0.52) | SMPD1FDPSGPR84PPARGPPARD | |
| Bicarbonate SCHEMBL3271999 | 0.87 | GPR84 (0.52) | SMPD1FDPSGPR84PPARGPPARD | |
| Bicarbonate SCHEMBL28426178 | 0.87 | GPR84 (0.52) | SMPD1FDPSGPR84PPARGPPARD | |
| Bicarbonate SCHEMBL28711950 | 0.87 | GPR84 (0.52) | SMPD1FDPSGPR84PPARGPPARD | |
| Acetic Acid SCHEMBL8065006 | 0.85 | GPR84 (0.50) | SMPD1FDPSGPR84PPARGPPARD | |
| Acetic Acid SCHEMBL2204888 | 0.85 | GPR84 (0.50) | SMPD1FDPSGPR84PPARGPPARD | |
| Oxalic Acid SCHEMBL28535006 | 0.85 | GPR84 (0.50) | SMPD1FDPSGPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3257890-B1 | CROSSLINKABLE COMPOSITION | ALLNEX NETHERLANDS BV (NL) | 2021-06-02 | — | — | EP | disclosed |
| CN-108112256-B | Improved coating system, use thereof for coating a component and component for a wind turbine thus coated | 美凯威奇兄弟有限责任两合公司 | 2021-04-06 | — | — | CN | disclosed |
| CN-107532035-B | Improved coating system, use thereof for coating components and components coated thereby for agricultural and construction machines | 美凯威奇兄弟有限责任两合公司 | 2020-11-03 | — | — | CN | disclosed |
| CN-107531849-B | Improved coating system, use thereof for coating components and components coated thereby for rail vehicles and aircraft | 美凯威奇兄弟有限责任两合公司 | 2020-11-03 | — | — | CN | disclosed |
| EP-3085748-B1 | COATINGS | JOTUN AS (NO) | 2017-12-27 | — | — | EP | disclosed |
| EP-3257890-A1 | CROSSLINKABLE COMPOSITION | Allnex Netherlands B.V. (NL) | 2017-12-20 | — | — | EP | disclosed |
| EP-2985308-B1 | CROSSLINKABLE COMPOSITION | ALLNEX NETHERLANDS BV (NL) | 2017-07-19 | — | — | EP | disclosed |
| US-9534081-B2 | Crosslinkable composition crosslinkable with a latent base catalyst | NUPLEX RESINS B.V. (NL) | 2017-01-03 | — | — | US | disclosed |
| EP-3085748-A1 | COATINGS | Jotun A/S (NO) | 2016-10-26 | — | — | EP | disclosed |
| EP-2556106-B1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS BV (NL) | 2016-08-10 | — | — | EP | disclosed |
| US-20130210986-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-08-15 | — | — | US | disclosed |
| US-20130053505-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-02-28 | — | — | US | disclosed |
| US-20130041091-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2013-02-14 | — | — | US | disclosed |
| EP-2556106-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556108-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556107-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | Nuplex Resins B.V. (NL) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011124664-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124663-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011124665-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | NUPLEX RESINS B.V. (NL) | 2011-10-13 | — | — | WO | disclosed |
| EP-2374836-A1 | Crosslinkable composition crosslinkable with a latent base catalyst. | Nuplex Resins B.V. (NL) | 2011-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041091-A1 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST | ARL1, ASH2L, COL1A1 | SMPD1 4035/4885FDPS 4826/4885GPR84 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.